Need help finding what you are looking for?
Contact Us
PUBLISHER: Transparency Market Research | PRODUCT CODE: 1592698
PUBLISHER: Transparency Market Research | PRODUCT CODE: 1592698
Viral Vectors-Based Gene Therapy for Non-Human Primates Market Type of Vector, Therapeutic Area; - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Viral Vectors-Based Gene Therapy for Non-Human Primates Market - Scope of Report
TMR's report on the global viral vectors-based gene therapy for non-human primates market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global viral vectors-based gene therapy for non-human primates market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global viral vectors-based gene therapy for non-human primates market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the viral vectors-based gene therapy for non-human primates market.
| Market Snapshot | |
|---|---|
| Market Value in 2023 | US$ 29.97 Mn |
| Market Value in 2034 | US$ 92.76 Mn |
| CAGR | 11% |
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global viral vectors-based gene therapy for non-human primates market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global viral vectors-based gene therapy for non-human primates market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global viral vectors-based gene therapy for non-human primates market.
The report delves into the competitive landscape of the global viral vectors-based gene therapy for non-human primates market. Key players operating in the global viral vectors-based gene therapy for non-human primates market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global viral vectors-based gene therapy for non-human primates market profiled in this report.
Key Questions Answered in Global viral vectors-based gene therapy for non-human primates Market Report:
- What is the sales/revenue generated by viral vectors-based gene therapy for non-human primates across all regions during the forecast period?
- What are the opportunities in the global viral vectors-based gene therapy for non-human primates market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2034?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Viral Vectors-Based Gene Therapy for Non-Human Primates Market - Research Objectives and Research Approach
The comprehensive report on the global viral vectors-based gene therapy for non-human primates market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global viral vectors-based gene therapy for non-human primates market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global viral vectors-based gene therapy for non-human primates market.
Product Code: TMRGL86394
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Viral Vectors-based Gene Therapy for Non-human Primates Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Vector Type Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Viral Vectors-based Gene Therapy for Non-human Primates Market Analysis and Forecasts, 2020-2034
- 4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
- 5.1. Recent Advancements in Viral Vectors Technology
- 5.2. List of Leading CROs offering Non-human Primates based Preclinical Testing Services
- 5.3. PORTER's Analysis on Viral Vectors for Non-human Primates Industry
- 5.4. Key Shortlisting Metrics for End-users
- 5.5. Regional Distribution of Non-human Primate Preclinical Studies
- 5.6. Key Industry Events (Partnership, Collaborations, Product approvals, merger & acquisitions)
- 5.7. Impact of COVID-19 Pandemic on Viral Vectors for Non-human Primates Industry
6. Global Viral Vectors-based Gene Therapy for Non-human Primates Market Analysis and Forecasts, By Vector Type
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast By Vector Type, 2020-2034
- 6.3.1. Adenoviral Vectors
- 6.3.2. Adeno-associated Vectors
- 6.3.3. Retroviral Vectors
- 6.3.4. Lentiviral Vectors
- 6.3.5. Other Vectors
- 6.4. Market Attractiveness By Vector Type
7. Global Viral Vectors-based Gene Therapy for Non-human Primates Market Analysis and Forecasts, By Type of Non-human Primate
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast By Type of Non-human Primate, 2020-2034
- 7.3.1. Marmosets
- 7.3.2. Rhesus Macaques
- 7.3.3. Cynomolgus Monkey
- 7.3.4. Others
- 7.4. Market Attractiveness By Type of Non-human Primate
8. Global Viral Vectors-based Gene Therapy for Non-human Primates Market Analysis and Forecasts, By Technology
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast By Technology, 2020-2034
- 8.3.1. Genetic Disorders
- 8.3.2. Infectious Diseases
- 8.3.3. Oncological Disorders
- 8.3.4. Neurodegenerative Disorders
- 8.3.5. Other Disorders
- 8.4. Market Attractiveness By Technology
9. Global Viral Vectors-based Gene Therapy for Non-human Primates Market Analysis and Forecasts, By Region
- 9.1. Key Findings
- 9.2. Market Value Forecast By Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness By Country/Region
10. North America Viral Vectors-based Gene Therapy for Non-human Primates Market Analysis and Forecast
- 10.1. Introduction
- 10.1.1. Key Findings
- 10.2. Market Value Forecast By Vector Type, 2020-2034
- 10.2.1. Adenoviral Vectors
- 10.2.2. Adeno-associated Vectors
- 10.2.3. Retroviral Vectors
- 10.2.4. Lentiviral Vectors
- 10.2.5. Other Vectors
- 10.3. Market Value Forecast By Type of Non-human Primate , 2020-2034
- 10.3.1. Marmosets
- 10.3.2. Rhesus Macaques
- 10.3.3. Cynomolgus Monkey
- 10.3.4. Others
- 10.4. Market Value Forecast By Technology, 2020-2034
- 10.4.1. Genetic Disorders
- 10.4.2. Infectious Diseases
- 10.4.3. Oncological Disorders
- 10.4.4. Neurodegenerative Disorders
- 10.4.5. Other Disorders
- 10.5. Market Value Forecast By Country, 2020-2034
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Vector Type
- 10.6.2. By Type of Non-human Primate
- 10.6.3. By Technology
- 10.6.4. By Country
11. Europe Viral Vectors-based Gene Therapy for Non-human Primates Market Analysis and Forecast
- 11.1. Introduction
- 11.1.1. Key Findings
- 11.2. Market Value Forecast By Vector Type, 2020-2034
- 11.2.1. Adenoviral Vectors
- 11.2.2. Adeno-associated Vectors
- 11.2.3. Retroviral Vectors
- 11.2.4. Lentiviral Vectors
- 11.2.5. Other Vectors
- 11.3. Market Value Forecast By Type of Non-human Primate, 2020-2034
- 11.3.1. Marmosets
- 11.3.2. Rhesus Macaques
- 11.3.3. Cynomolgus Monkey
- 11.3.4. Others
- 11.4. Market Value Forecast By Technology, 2020-2034
- 11.4.1. Genetic Disorders
- 11.4.2. Infectious Diseases
- 11.4.3. Oncological Disorders
- 11.4.4. Neurodegenerative Disorders
- 11.4.5. Other Disorders
- 11.5. Market Value Forecast By Country, 2020-2034
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Italy
- 11.5.5. Spain
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Vector Type
- 11.6.2. By Type of Non-human Primate
- 11.6.3. By Technology
- 11.6.4. By Country
12. Asia Pacific Viral Vectors-based Gene Therapy for Non-human Primates Market Analysis and Forecast
- 12.1. Introduction
- 12.1.1. Key Findings
- 12.2. Market Value Forecast By Vector Type, 2020-2034
- 12.2.1. Adenoviral Vectors
- 12.2.2. Adeno-associated Vectors
- 12.2.3. Retroviral Vectors
- 12.2.4. Lentiviral Vectors
- 12.2.5. Other Vectors
- 12.3. Market Value Forecast By Type of Non-human Primate, 2020-2034
- 12.3.1. Marmosets
- 12.3.2. Rhesus Macaques
- 12.3.3. Cynomolgus Monkey
- 12.3.4. Others
- 12.4. Market Value Forecast By Technology, 2020-2034
- 12.4.1. Genetic Disorders
- 12.4.2. Infectious Diseases
- 12.4.3. Oncological Disorders
- 12.4.4. Neurodegenerative Disorders
- 12.4.5. Other Disorders
- 12.5. Market Value Forecast By Country, 2020-2034
- 12.5.1. China
- 12.5.2. India
- 12.5.3. Japan
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Vector Type
- 12.6.2. By Type of Non-human Primate
- 12.6.3. By Technology
- 12.6.4. By Country
13. Latin America Viral Vectors-based Gene Therapy for Non-human Primates Market Analysis and Forecast
- 13.1. Introduction
- 13.1.1. Key Findings
- 13.2. Market Value Forecast By Vector Type, 2020-2034
- 13.2.1. Adenoviral Vectors
- 13.2.2. Adeno-associated Vectors
- 13.2.3. Retroviral Vectors
- 13.2.4. Lentiviral Vectors
- 13.2.5. Other Vectors
- 13.3. Market Value Forecast By Type of Non-human Primate , 2020-2034
- 13.3.1. Marmosets
- 13.3.2. Rhesus Macaques
- 13.3.3. Cynomolgus Monkey
- 13.3.4. Others
- 13.4. Market Value Forecast By Technology, 2020-2034
- 13.4.1. Genetic Disorders
- 13.4.2. Infectious Diseases
- 13.4.3. Oncological Disorders
- 13.4.4. Neurodegenerative Disorders
- 13.4.5. Other Disorders
- 13.5. Market Value Forecast By Country, 2020-2034
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Vector Type
- 13.6.2. By Type of Non-human Primate
- 13.6.3. By Technology
- 13.6.4. By Country
14. Middle East & Africa Viral Vectors-based Gene Therapy for Non-human Primates Market Analysis and Forecast
- 14.1. Introduction
- 14.1.1. Key Findings
- 14.2. Market Value Forecast By Vector Type, 2020-2034
- 14.2.1. Adenoviral Vectors
- 14.2.2. Adeno-associated Vectors
- 14.2.3. Retroviral Vectors
- 14.2.4. Lentiviral Vectors
- 14.2.5. Other Vectors
- 14.3. Market Value Forecast By Type of Non-human Primate, 2020-2034
- 14.3.1. Marmosets
- 14.3.2. Rhesus Macaques
- 14.3.3. Cynomolgus Monkey
- 14.3.4. Others
- 14.4. Market Value Forecast By Technology, 2020-2034
- 14.4.1. Genetic Disorders
- 14.4.2. Infectious Diseases
- 14.4.3. Oncological Disorders
- 14.4.4. Neurodegenerative Disorders
- 14.4.5. Other Disorders
- 14.5. Market Value Forecast By Country, 2020-2034
- 14.5.1. GCC
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
- 14.6. Market Attractiveness Analysis
- 14.6.1. By Vector Type
- 14.6.2. By Type of Non-human Primate
- 14.6.3. By Technology
- 14.6.4. By Country
15. Competition Landscape
- 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
- 15.2. Company Profiles
- 15.2.1. CRISPR Therapeutics AG
- 15.2.1.1. Company Overview
- 15.2.1.2. Financial Overview
- 15.2.1.3. Product Portfolio
- 15.2.1.4. Business Strategies
- 15.2.1.5. Recent Developments
- 15.2.2. Voyager Therapeutics, Inc.
- 15.2.2.1. Company Overview
- 15.2.2.2. Financial Overview
- 15.2.2.3. Product Portfolio
- 15.2.2.4. Business Strategies
- 15.2.2.5. Recent Developments
- 15.2.3. Sarepta Therapeutics, Inc.
- 15.2.3.1. Company Overview
- 15.2.3.2. Financial Overview
- 15.2.3.3. Product Portfolio
- 15.2.3.4. Business Strategies
- 15.2.3.5. Recent Developments
- 15.2.4. Neuracle Genetics
- 15.2.4.1. Company Overview
- 15.2.4.2. Financial Overview
- 15.2.4.3. Product Portfolio
- 15.2.4.4. Business Strategies
- 15.2.4.5. Recent Developments
- 15.2.5. Beacon Therapeutics
- 15.2.5.1. Company Overview
- 15.2.5.2. Financial Overview
- 15.2.5.3. Product Portfolio
- 15.2.5.4. Business Strategies
- 15.2.5.5. Recent Developments
- 15.2.6. REGENXBIO Inc.
- 15.2.6.1. Company Overview
- 15.2.6.2. Financial Overview
- 15.2.6.3. Product Portfolio
- 15.2.6.4. Business Strategies
- 15.2.6.5. Recent Developments
- 15.2.7. 4D Molecular Therapeutics
- 15.2.7.1. Company Overview
- 15.2.7.2. Financial Overview
- 15.2.7.3. Product Portfolio
- 15.2.7.4. Business Strategies
- 15.2.7.5. Recent Developments
- 15.2.8. Rocket Pharmaceuticals, Inc.
- 15.2.8.1. Company Overview
- 15.2.8.2. Financial Overview
- 15.2.8.3. Product Portfolio
- 15.2.8.4. Business Strategies
- 15.2.8.5. Recent Developments
- 15.2.1. CRISPR Therapeutics AG
Product Code: TMRGL86394
Viral Vectors-Based Gene Therapy for Non-Human Primates Market
Viral Vectors-Based Gene Therapy for Non-Human Primates Industry
Viral Vectors-Based Gene Therapy for Non-Human Primates Market Size
Viral Vectors-Based Gene Therapy for Non-Human Primates Market Share
Viral Vectors-Based Gene Therapy for Non-Human Primates Market Growth
Viral Vectors-Based Gene Therapy for Non-Human Primates Market Analysis
Viral Vectors-Based Gene Therapy for Non-Human Primates Market Demand
Viral Vectors-Based Gene Therapy for Non-Human Primates Market Forecast
Viral Vectors-Based Gene Therapy for Non-Human Primates Market Trends
List of Tables
- Table 01: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Type of Vector, 2020-2034
- Table 02: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Type of Non-human Primate, 2020-2034
- Table 03: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
- Table 04: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, By End-user, 2020-2034
- Table 05: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Region, 2020-2034
- Table 06: North America - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Country, 2020-2034
- Table 07: North America - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Type of Vector, 2020-2034
- Table 08: North America - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Technology, 2020-2034
- Table 09: North America - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
- Table 10: North America - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, By End-user, 2020-2034
- Table 11: Europe - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
- Table 12: Europe - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Type of Vector, 2020-2034
- Table 13: Europe - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Type of Non-human Primate, 2020-2034
- Table 14: Europe - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
- Table 15: Europe - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, By End-user, 2020-2034
- Table 16: Asia Pacific Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
- Table 17: Asia Pacific - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Type of Vector, 2020-2034
- Table 18: Asia Pacific - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Type of Non-human Primate, 2020-2034
- Table 19: Asia Pacific - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
- Table 20: Asia Pacific - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, By End-user, 2020-2034
- Table 21: Latin America - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
- Table 22: Latin America - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Type of Vector, 2020-2034
- Table 23: Latin America - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Type of Non-human Primate, 2020-2034
- Table 24: Latin America - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
- Table 25: Latin America - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, By End-user, 2020-2034
- Table 26: Middle East & Africa - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
- Table 27: Middle East & Africa - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Type of Vector, 2020-2034
- Table 28: Middle East & Africa - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Type of Non-human Primate, 2020-2034
- Table 29: Middle East & Africa - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
- Table 30: Middle East & Africa - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, By End-user, 2020-2034
List of Figures
- Figure 01: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast, 2020-2034
- Figure 02: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share, by Type of Vector, 2023
- Figure 03: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share, by Type of Non-human Primate, 2023
- Figure 04: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share, by Therapeutic Area, 2023
- Figure 05: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share, by End-user, 2023
- Figure 06: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share, By Region, 2023
- Figure 07: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, by Type of Vector, 2023 and 2034
- Figure 08: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Share Analysis, by Type of Vector, 2023
- Figure 09: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Share Analysis, by Type of Vector, 2034
- Figure 10: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Type of Vector, 2024-2034
- Figure 11: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn), by Adenoviral Vectors, 2020-2034
- Figure 12: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share Analysis, by Adenoviral Vectors, 2023 and 2034
- Figure 13: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn), by Adeno-associated Vectors, 2020-2034
- Figure 14: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share Analysis, by Adeno-associated Vectors, 2023 and 2034
- Figure 15: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn), by Retroviral Vectors, 2020-2034
- Figure 16: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share Analysis, by Retroviral Vectors, 2023 and 2034
- Figure 17: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn), by Lentiviral Vectors, 2020-2034
- Figure 18: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share Analysis, by Lentiviral Vectors, 2023 and 2034
- Figure 19: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn), by Other Vectors, 2020-2034
- Figure 20: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share Analysis, by Other Vectors, 2023 and 2034
- Figure 21: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, by Type of Non-human Primate, 2023 and 2034
- Figure 22: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Share Analysis, by Type of Non-human Primate, 2023
- Figure 23: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Share Analysis, by Type of Non-human Primate, 2034
- Figure 24: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Type of Non-human Primate, 2024-2034
- Figure 25: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn), by Marmosets, 2020-2034
- Figure 26: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share Analysis, by Marmosets, 2023 and 2034
- Figure 27: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn), by Rhesus Macaques, 2020-2034
- Figure 28: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share Analysis, by Rhesus Macaques, 2023 and 2034
- Figure 29: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn), by Cynomolgus Monkey, 2020-2034
- Figure 30: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share Analysis, by Cynomolgus Monkey, 2023 and 2034
- Figure 31: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn), by Others, 2020-2034
- Figure 32: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share Analysis, by Others, 2023 and 2034
- Figure 33: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
- Figure 34: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Share Analysis, by Therapeutic Area, 2023
- Figure 35: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Share Analysis, by Therapeutic Area, 2034
- Figure 36: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Derivatives Type, 2024-2034
- Figure 37: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn), by Genetic Disorders, 2020-2034
- Figure 38: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share Analysis, by Genetic Disorders, 2023 and 2034
- Figure 39: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn), by Infectious Diseases, 2020-2034
- Figure 40: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share Analysis, by Infectious Diseases, 2023 and 2034
- Figure 41: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn), by Oncological Disorders, 2020-2034
- Figure 42: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share Analysis, by Oncological Disorders, 2023 and 2034
- Figure 43: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn), by Neurodegenerative Disorders, 2020-2034
- Figure 44: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share Analysis, by Neurodegenerative Disorders, 2023 and 2034
- Figure 45: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn), by Other Disorders, 2020-2034
- Figure 46: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share Analysis, by Other Disorders, 2023 and 2034
- Figure 47: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, By End-user, 2023 and 2034
- Figure 48: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Share Analysis, By End-user, 2023
- Figure 49: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Share Analysis, By End-user, 2034
- Figure 50: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, By End-user, 2024-2034
- Figure 51: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn), by Pharmaceutical and Biotechnology Companies, 2020-2034
- Figure 52: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share Analysis, by Pharmaceutical and Biotechnology Companies, 2023 and 2034
- Figure 53: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn), by Contract Research Organizations, 2020-2034
- Figure 54: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share Analysis, by Contract Research Organizations, 2023 and 2034
- Figure 55: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn), by Academic and Research Institutes, 2020-2034
- Figure 56: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share Analysis, by Academic and Research Institutes, 2023 and 2034
- Figure 57: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share Analysis, by Region, 2023 and 2034
- Figure 58: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Share Analysis, by Region, 2023
- Figure 59: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Share Analysis, by Region, 2034
- Figure 60: Global Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Region, 2023-2034
- Figure 61: North America - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
- Figure 62: North America - Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share Analysis, by Country, 2023 and 2034
- Figure 63: North America - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Country, 2024-2034
- Figure 64: North America - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, by Type of Vector, 2023 and 2034
- Figure 65: North America - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Type of Vector, 2024-2034
- Figure 66: North America - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, by Type of Non-human Primate, 2023 and 2034
- Figure 67: North America - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Type of Non-human Primate, 2024-2034
- Figure 68: North America - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
- Figure 69: North America - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Therapeutic Area, 2024-2034
- Figure 70: North America - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, By End-user, 2023 and 2034
- Figure 71: North America - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, By End-user, 2024-2034
- Figure 72: Europe - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
- Figure 73: Europe - Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
- Figure 74: Europe - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
- Figure 75: Europe - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, by Type of Vector, 2023 and 2034
- Figure 76: Europe - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Type of Vector, 2024-2034
- Figure 77: Europe - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, by Type of Non-human Primate, 2023 and 2034
- Figure 78: Europe - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Type of Non-human Primate, 2024-2034
- Figure 79: Europe - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
- Figure 80: Europe - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Therapeutic Area, 2024-2034
- Figure 81: Europe - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, By End-user, 2023 and 2034
- Figure 82: Europe - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, By End-user, 2024-2034
- Figure 83: Asia Pacific - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
- Figure 84: Asia Pacific - Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
- Figure 85: Asia Pacific - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
- Figure 86: Asia Pacific - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, by Type of Vector, 2023 and 2034
- Figure 87: Asia Pacific - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Type of Vector, 2024-2034
- Figure 88: Asia Pacific - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, by Type of Non-human Primate, 2023 and 2034
- Figure 89: Asia Pacific - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Type of Non-human Primate, 2024-2034
- Figure 90: Asia Pacific - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
- Figure 91: Asia Pacific - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Therapeutic Area, 2024-2034
- Figure 92: Asia Pacific - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, By End-user, 2023 and 2034
- Figure 93: Asia Pacific - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, By End-user, 2024-2034
- Figure 94: Latin America - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
- Figure 95: Latin America - Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
- Figure 96: Latin America - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
- Figure 97: Latin America - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, by Type of Vector, 2023 and 2034
- Figure 98: Latin America - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Type of Vector, 2024-2034
- Figure 99: Latin America - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, by Type of Non-human Primate, 2023 and 2034
- Figure 100: Latin America - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Type of Non-human Primate, 2024-2034
- Figure 101: Latin America - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
- Figure 102: Latin America - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Therapeutic Area, 2024-2034
- Figure 103: Latin America - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, By End-user, 2023 and 2034
- Figure 104: Latin America - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, By End-user, 2024-2034
- Figure 105: Middle East & Africa - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
- Figure 106: Middle East & Africa - Viral Vectors-based Gene Therapy for Non-human Primates Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
- Figure 107: Middle East & Africa - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
- Figure 108: Middle East & Africa - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, by Type of Vector, 2023 and 2034
- Figure 109: Middle East & Africa - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Type of Vector, 2024-2034
- Figure 110: Middle East & Africa - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, by Type of Non-human Primate, 2023 and 2034
- Figure 111: Middle East & Africa - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Type of Non-human Primate, 2024-2034
- Figure 112: Middle East & Africa - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
- Figure 113: Middle East & Africa - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, by Therapeutic Area, 2024-2034
- Figure 114: Middle East & Africa - Viral Vectors-based Gene Therapy for Non-human Primates Market Value (US$ Mn) Share Analysis, By End-user, 2023 and 2034
- Figure 115: Middle East & Africa - Viral Vectors-based Gene Therapy for Non-human Primates Market Attractiveness Analysis, By End-user, 2024-2034
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.